Skip to content

A five-year retrospective study of the efficacy and safety of modified trabeculectomy for PACG patients

A five-year retrospective study of the efficacy and safety of modified trabeculectomy for PACG patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077915
Enrollment
Unknown
Registered
2023-11-23
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary angle-closure glaucoma

Interventions

modified-trabeculectomy group:NA
trabeculectomy group:NA

Sponsors

Jiangsu Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) All patients were 18-80 years at the time of enrollment, able to understand and provide informed consent, and scheduled for glaucoma surgery; (2) A glaucoma diagnosis of primary angle-closure glaucoma (PACG) which was defined as primary angle closure with glaucomatous optic neuropathy; (3) With glaucomatous optic nerve damage and corresponding visual field defects; (4) With the maximum or tolerable medicament, elevated intraocular pressure may still cause further damage to the optic nerve, or poor compliance; (5) No other histories of fundus disease and eye surgery.

Exclusion criteria

Exclusion criteria: 1. Failure to successfully complete the surgery; 2. Key data missing.

Design outcomes

Primary

MeasureTime frame
Operation success rate;Intraocular pressure;complication;The number of intraocular pressure lowering drugs;

Countries

China

Contacts

Public ContactHong Sun

Jiangsu Province Hospital

hollysh8@sina.com+86 133 9076 6677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026